These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 23351056)

  • 41. The role of L- and T-type calcium channels in local and remote calcium responses in rat mesenteric terminal arterioles.
    Braunstein TH; Inoue R; Cribbs L; Oike M; Ito Y; Holstein-Rathlou NH; Jensen LJ
    J Vasc Res; 2009; 46(2):138-51. PubMed ID: 18765948
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal microcirculation and calcium channel subtypes.
    Homma K; Hayashi K; Yamaguchi S; Fujishima S; Hori S; Itoh H
    Curr Hypertens Rev; 2013 Aug; 9(3):182-6. PubMed ID: 24479750
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Hydrogen sulfide evokes neurite outgrowth and expression of high-voltage-activated Ca2+ currents in NG108-15 cells: involvement of T-type Ca2+ channels.
    Nagasawa K; Tarui T; Yoshida S; Sekiguchi F; Matsunami M; Ohi A; Fukami K; Ichida S; Nishikawa H; Kawabata A
    J Neurochem; 2009 Feb; 108(3):676-84. PubMed ID: 19054275
    [TBL] [Abstract][Full Text] [Related]  

  • 44. L-/N-type calcium channel blockers and proteinuria.
    Ando K
    Curr Hypertens Rev; 2013 Aug; 9(3):210-8. PubMed ID: 24479751
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional importance of T-type voltage-gated calcium channels in the cardiovascular and renal system: news from the world of knockout mice.
    Hansen PB
    Am J Physiol Regul Integr Comp Physiol; 2015 Feb; 308(4):R227-37. PubMed ID: 25519728
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Divergent renal vasodilator action of L- and T-type calcium antagonists in vivo.
    Honda M; Hayashi K; Matsuda H; Kubota E; Tokuyama H; Okubo K; Takamatsu I; Ozawa Y; Saruta T
    J Hypertens; 2001 Nov; 19(11):2031-7. PubMed ID: 11677369
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Proliferation of human lens epithelial cells (HLE-B3) is inhibited by blocking of voltage-gated calcium channels.
    Meissner A; Noack T
    Pflugers Arch; 2008 Oct; 457(1):47-59. PubMed ID: 18446362
    [TBL] [Abstract][Full Text] [Related]  

  • 48. T-type Ca channel blockers in patients with chronic kidney disease in clinical practice.
    Abe M; Okada K; Soma M
    Curr Hypertens Rev; 2013 Aug; 9(3):202-9. PubMed ID: 24479749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of N- and T-type calcium channel blocker on proteinuria, blood pressure and kidney function in hypertensive patients: a meta-analysis.
    Thamcharoen N; Susantitaphong P; Wongrakpanich S; Chongsathidkiet P; Tantrachoti P; Pitukweerakul S; Avihingsanon Y; Praditpornsilpa K; Jaber BL; Eiam-Ong S
    Hypertens Res; 2015 Dec; 38(12):847-55. PubMed ID: 26134125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Voltage-gated calcium channels].
    Kamkin AG; Kiseleva IS; Kirishchuk SI; Lozinskiĭ IT
    Usp Fiziol Nauk; 2006; 37(4):3-33. PubMed ID: 17139998
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Metabotropic regulation of RhoA/Rho-associated kinase by L-type Ca2+ channels: new mechanism for depolarization-evoked mammalian arterial contraction.
    Fernández-Tenorio M; Porras-González C; Castellano A; Del Valle-Rodríguez A; López-Barneo J; Ureña J
    Circ Res; 2011 May; 108(11):1348-57. PubMed ID: 21493898
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of voltage-gated calcium channels in potassium-stimulated aldosterone secretion from rat adrenal zona glomerulosa cells.
    Uebele VN; Nuss CE; Renger JJ; Connolly TM
    J Steroid Biochem Mol Biol; 2004 Oct; 92(3):209-18. PubMed ID: 15555914
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Functional impairment of renal afferent arteriolar voltage-gated calcium channels in rats with diabetes mellitus.
    Carmines PK; Ohishi K; Ikenaga H
    J Clin Invest; 1996 Dec; 98(11):2564-71. PubMed ID: 8958219
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Renal and vascular protective effects of cilnidipine in patients with essential hypertension.
    Morimoto S; Yano Y; Maki K; Iwasaka T
    J Hypertens; 2007 Oct; 25(10):2178-83. PubMed ID: 17885563
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Beneficial effect of T-type calcium channel blockers on endothelial function in patients with essential hypertension.
    Oshima T; Ozono R; Yano Y; Higashi Y; Teragawa H; Miho N; Ishida T; Ishida M; Yoshizumi M; Kambe M
    Hypertens Res; 2005 Nov; 28(11):889-94. PubMed ID: 16555577
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effects of calcium antagonists on renal hemodynamics.
    Epstein M; Loutzenhiser RD
    Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):10-4. PubMed ID: 2220795
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T-type and L-type calcium channel blockers exert opposite effects on renin secretion and renin gene expression in conscious rats.
    Wagner C; Krämer BK; Hinder M; Kieninger M; Kurtz A
    Br J Pharmacol; 1998 Jun; 124(3):579-85. PubMed ID: 9647484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pathophysiological significance of T-type Ca2+ channels: role of T-type Ca2+ channels in renal microcirculation.
    Hayashi K; Wakino S; Homma K; Sugano N; Saruta T
    J Pharmacol Sci; 2005 Nov; 99(3):221-7. PubMed ID: 16293936
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Efonidipine hydrochloride: a dual blocker of L- and T-type ca(2+) channels.
    Tanaka H; Shigenobu K
    Cardiovasc Drug Rev; 2002; 20(1):81-92. PubMed ID: 12070536
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Physiology, Pathology, and Pharmacology of Voltage-Gated Calcium Channels and Their Future Therapeutic Potential.
    Zamponi GW; Striessnig J; Koschak A; Dolphin AC
    Pharmacol Rev; 2015 Oct; 67(4):821-70. PubMed ID: 26362469
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.